INHIBITION OF CELL-ADHESION TO LENS CAPSULE BY LCM-1910, AN RGD-DERIVED PEPTIDE

被引：11

作者：

PALMADE, F ^{[1
]}

SECHOYCHAMBON, O ^{[1
]}

DEVAINS, JBR ^{[1
]}

COQUELET, C ^{[1
]}

BONNE, C ^{[1
]}

机构：

[1] UNIV MONTPELLIER 1,FAC PHARM,PHYSIOL CELLULAIRE LAB,F-34060 MONTPELLIER,FRANCE

来源：

JOURNAL OF OCULAR PHARMACOLOGY | 1994年 / 10卷 / 04期

关键词：

D O I：

10.1089/jop.1994.10.623

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Opacification of the posterior lens capsule, (secondary cataract), is one of the major complications of extracapsular cataract extraction. The lens epithelial cells remaining after surgery migrate and proliferate along posterior capsule, and give rise to structures such as pearls and cells with contractile properties, which considerably hamper vision. One pharmacological approach aimed at limiting this phenomenon would be to stop this cell migration, thus inhibiting their proliferation. It has been shown that cells adhere and migrate on their support via adhesion molecules such as integrins. Generally, the tripeptide sequence Arg-Gly-Asp (RGD) is the recognition motif for these receptors. In this study, cell adhesion inhibition in the presence of RGD peptides and derivatives was measured on extracellular matrix and lens capsule. One of these compounds, the [N-alpha-acetyl-N-G(H+)-arginyl]-glycyl-[C-beta(H)-C-alpha-benzyl]-aspartamid-HCl] (LCM 1910), significantly inhibited cell migration at millimolar concentrations, and could be of interest in prevention of secondary cataract.

引用

页码：623 / 632

页数：10

共 27 条

[1]

Kappelhof J.P., Vrensen G.F., The pathology of after-cataract, Acia Ophthalmol., 205, pp. 13-24, (1992)

[2]

Ohadi C., Moreira H., Mc Donnell P.J., Posterior capsule opacification, Curr. Opin. Ophthalmol., 2, pp. 46-52, (1991)

[3]

Apple D.J., Solomon K.D., Tetz M.R., Assia E.I., Holland E.Y., Legier U.F.C., Tsai J.C., Castaneda V.E., Hoggatt J.P., Kostick A.M.P. Posterior capsule opacification, Surv. Ophthalmol., 37, pp. 73-116, (1992)

[4]

Lieslang T.J., Bourne W.M., Ilstrup D.M., Secondary surgical and Nd: Yag laser discussions, Am. J. Ophthalmol., 100, pp. 510-519, (1985)

[5]

Rieckmann-Barger L., Florine C.W., Larson R.S., Lindstom R.L., Retinal detachment after Nd: Yag laser posterior capsulotomy, Am. J. Ophthalmol., 107, pp. 531-536, (1989)

[6]

Solomon K.D., Legier U.F.C., Kostick A.M.P., Capsular opacification after cataract surgery, Curr. Opin. Ophthalmol., 3, pp. 46-51, (1992)

[7]

Tarsio J.F., Emery J.M., Kelleher P.J., Tarsio M., Lee H., Potter D.E., Lam D.M.K., Cytotoxic effects of a monoclonal antibody-ricin A immunotoxin on human lens epithelial cells in culture, Invest. Ophthalmol. Vis. Sci., 31, (1990)

[8]

Hansen T.J., Tyndall R., Soll D.B., Methotrexate-Anticollagen conjugate inhibits in vitro lens cell outgrowth, Invest. Ophthalmol. Vis. Sci., 28, pp. 1206-1209, (1987)

[9]

Hartmann C., Wiedemann P., Gothe K., Weiler M., Heimann K., Prévention de la cataracte secondaire par application endocapsulaire de l'antimitotique daunomycine, Ophtalmologie, 4, pp. 102-106, (1990)

[10]

Legier U.F.C., Apple D.J., Assia E.T., Bluestein E.L.C., Castaneda V.E., Mowbray S.L., Inhibition of posterior caspsule opacification : The effect of colchicine in a sustained drug delivery system, J. Cataract Refract. Surg., 19, pp. 462-470, (1993)

← 1 2 3 →